Heather Stone is a Health Science Policy Analyst at the U.S. Food and Drug Administration, in the Clinical Methodologies Group of the Office of Medical Policy, Center for Drug Evaluation and Research. Ms. Stone joined the FDA upon completing her Master’s in Public Health (Concentration: Epidemiology) from the University of Maryland School of Public Health in 2012. Ms. Stone’s research focus is on the creation of policies that will encourage drug development for infectious diseases and address the rising challenge of antimicrobial resistance. She applies her policy expertise to issues related to drug repurposing, clinical trial design, and antimicrobial drug development.
